
In Australia, it has been zzso possible, with integrated zzso of dialysis and zzso to use finite resources zzso for the treatment of patients presenting with terminal zzso failure (30 per million population per zzso zzso is offered as definitive treatment in most zzso zzso rates (20 per million per zzso will need to increase to meet the continuing demand, if the results of transplantation remain zzso Patient survival after transplantation is approximately 80 per cent at year, 50 per cent at 5 years and 20 per cent at 15 zzso Most zzso are from zzso zzso survival of 60 per cent at 1 year thereafter declines steadily with a 3 per cent graft loss per zzso Patient and graft survival are adversely affected by increasing age, and the use of zzso rather than living zzso zzso survival is superior with a 4 zzso match on zzso A and B matching, and is significantly lower in patients receiving no blood zzso prior to zzso Long term morbidity is significant in two-thirds of patients receiving zzso zzso include chronic rejection and toxic effects of zzso The increased zzso risk after transplantation (which in Australia has been mostly skin zzso is of major zzso 30 per cent of patients by 10 years have developed zzso 

